BioMarin Begins Mid Stage Study on Gene Therapy Candidate – Zacks.com
Zacks.com |
BioMarin Begins Mid Stage Study on Gene Therapy Candidate
Zacks.com The candidate enjoys Breakthrough Therapy designation in the United States. This designation facilitates and expedites development and review of new drugs to address unmet medical need in the treatment of a serious condition. The candidate has also … |
